FDA's sickle cell therapy approval help Black Minnesotans dream of 'life without any restrictions'

Roughly 100,000 Americans, most of whom are Black, are living with sickle cell disease. The recent Food and Drug Administration approval of two new gene therapies brings the promise of a cure.

Kyra Miles of Minnesota Public Radio shares how these therapies are reverberating in the sickle cell community.